Zevra Therapeutics (ZVRA)
Nasdaq • ZVRA • US4884452065
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 12.4% of free float sold short, 7.8 days to cover, cost to borrow 0.39%. Sign up for live short interest data.
Market Cap
691m USD | # 5536 in US
Volume
893.65k shares | 10.01m USD
Shares Outstanding
59.5m
Free Float Shares
90.74% | 53.99m
